Mielóma multiplex: vizsgálatok itt: Grúzia
1 of 1 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisNot yet taking people in GrúziaA Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
- Where
- Tbilisi
- Életkor
- 18 év and over
- People
- 258 worldwide
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT07477587